From a technical standpoint the chart on OPGEN looks like it will head upwards, but my personal opinion, I believe it is possible that the SP will take a dip in the following days with earnings report coming on March 25th; Alongside market uncertainty with treasury yields increasing, it’s possible that it heads to 1.90’s and even 1.80’s price points again.
There’s a very significant gap around (2.05-2.20) on the daily and smaller timeframes... unless the potential FDA decision or NMPA approval comes soon it’s possible that the gap will be filled.